SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
Amendment No. | 4 |

Uroplasty Inc.
(Name of Issuer)

Common Shares
(Title of Class of Securities)

917277-20-4
(CUSIP Number)

December 31, 2009
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 917277-20-4 13G/A Page 2 of 5 Pages

_____________________________________________________________________________
1. NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 Perkins Capital Management, Inc. 14-1501962
_____________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) [_]
 (b) [_]
_____________________________________________________________________________
3. SEC USE ONLY


_____________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION

 State of Minnesota

_____________________________________________________________________________
 5. SOLE VOTING POWER

 382,000
NUMBER OF _______________________________________________________________
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY EACH 0
REPORTING _______________________________________________________________
PERSON WITH 7. SOLE DISPOSITIVE POWER

 1,114,602
 _______________________________________________________________
 8. SHARED DISPOSITIVE POWER

 0
_____________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,114,602
_____________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 [_]
_____________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 7.3%
_____________________________________________________________________________
12. TYPE OF REPORTING PERSON*
 IA
_____________________________________________________________________________


 *SEE INSTRUCTIONS BEFORE FILLING OUT!


Item 1(a) Name of Issuer:

Uroplasty Inc.

Item 1(b) Address of Issuer's Principal Executive Offices:

5420 Feltl Rd
Minnetonka, MN 55343

Item 2(a) Name of Person Filing:

Perkins Capital Management, Inc.

Item 2(b) Address of Principal Business Office or, if None, Residence:

730 East Lake Street
Wayzata, MN 55391

Item 2(c) Citizenship:

State of Minnesota

Item 2(d) Title of Class of Securities:

Common Shares

Item 2(e) CUSIP Number:

917277-20-4

Item 3. If this statement is filed pursuant to Rules 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:

(a) [_] Broker or dealer registered under Section 15 of the Act (15 U.S.C.78o);
(b) [_] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C.78c);
(c) [_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C.78c);
(d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C.8a-8);
(e) [X] An Investment Adviser in accordance with Section 240. 13d-1(b)(1) (ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Section 240. 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Section 240. 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.80a-3);
(j) [_] Group, in accordance with Section 240. 13d-1(b)(1)(ii)(J).

If this statement is filed pursuant to Section 240 13d-1(c), check this box. [ ]

Item 4. Ownership.

(a) Amount beneficially owned:

1,114,602(includes 832,102 common equivalents and 282,500 warrants exerciseable within 60 days)

(b) Percent of class:

7.3%

(c) Number of shares as to which such person has:

(i) Sole power to vote or to direct the vote 382,000

(ii) Shared power to vote or to direct the vote 0

(iii) Sole power to dispose or to direct the disposition of 1,114,602 (includes 832,102 common equivalents and 282,500 warrants exerciseable within 60 days)

(iv) Shared power to dispose or to direct the disposition of 0

Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

n/a

Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company. n/a

Item 8. Identification and Classification of Members of the Group.

n/a

Item 9. Notice of Dissolution of Group.

n/a

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 10, 2010
(Date)

/S/ Richard C. Perkins
 _____________________________
 (Signature)

Richard C. Perkins EVP/Portfolio Manager

(Name/Title)
Uroplasty (AMEX:UPI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Uroplasty Charts.
Uroplasty (AMEX:UPI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Uroplasty Charts.